By, AW; Duhaime, R; Lodge, BA. The synthesis and spectra of 4-ethoxyamphetamine and its isomers. Forensic Sci. Int., 1 Jan 1991, 49 (2), 159–170. 494 kB. https://doi.org/10.1016/0379-0738(91)90075-T #4-EA MS,NMR,IR,UV
Hegadoren, KM; Greenshaw, AJ; Baker, GB; Martin-lverson, MT; Lodge, BA; Soin, S. 4-Ethoxyamphetamine: effects on intracranial self-stimulation and in vitro uptake and release of 3H-dopamine and 3H-serotonin in the brains of rats. J. Psychiatry Neurosci., 1 Jan 1994, 19 (1), 57–62. 910 kB.
Scorza, MC; Carrau, C; Silveira, R; Zapata-Torres, G; Cassels, BK; Reyes-Parada, M. Monoamine oxidase inhibitory properties of some methoxylated and alkylthio amphetamine derivatives. Biochem. Pharmacol., 15 Dec 1997, 54 (12), 1361–1369. 697 kB. https://doi.org/10.1016/S0006-2952(97)00405-X #7 4-EtOA
Vilches-Herrera, M; Miranda-Sepúlveda, J; Rebolledo-Fuentes, M; Fierro, A; Lühr, S; Iturriaga-Vasquez, P; Cassels, BK; Reyes-Parada, M. Naphthylisopropylamine and N-benzylamphetamine derivatives as monoamine oxidase inhibitors. Bioorg. Med. Chem., 15 Mar 2009, 17 (6), 2452–2460. 509 kB. https://doi.org/10.1016/j.bmc.2009.01.074
Glennon, RA; Raghupathi, R; Bartyzel, P; Teitler, M; Leonhardt, S. Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity. J. Med. Chem., 1 Feb 1992, 35 (4), 734–740. 1.1 MB. https://doi.org/10.1021/jm00082a014 #9 NMR
Foster, BC; Nantais, LM; Wilson, DL; By, AW; Zamecnik, J; Lodge, BA. Fungal metabolism of 4-substituted amphetamines. Xenobiotica, 1 Jan 1990, 20 (6), 583–590. 510 kB. https://doi.org/10.3109/00498259009046873 #1b GC,MS
Corrigall, WA; Robertson, JM; Coen, KM; Lodge, BA. The reinforcing and discriminative stimulus properties of para-ethoxy- and para-methoxyamphetamine. Pharmacol. Biochem. Behav., 1 Jan 1992, 41 (1), 165–169. 538 kB. https://doi.org/10.1016/0091-3057(92)90077-S #PEA
Buttar, HS; Moffatt, JH; Foster, BC. Developmental toxicity of 4-substituted amphetamines in mice. Reprod. Toxicol., 1 Jul 1996, 10 (4), 301–310. 710 kB. https://doi.org/10.1016/0890-6238(96)00059-7 #4-ETA
Hyperlab. Hyperlab new compounds. 29 Sep 2014. 232 kB. Note: Contains links to hyperlab.info that require elevated access/karma to follow.
Sáez-Briones, P; Hernández, A. MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology. Curr. Neuropharmacol., 1 Sep 2013, 11 (5), 521–534. 1.4 MB. https://doi.org/10.2174/1570159X11311050007 #4-EA
King, LA. Designer drugs related to amphetamine (1990–1996). JCLIC, 1 Jul 1996, 6 (3), 15-16. 562 kB. #20